Visibility Score
38/100
AI Mentions
60
AI Search Volume
6.9K
As of June 25, 2026, Nihon Kohden (nihonkohden.com) has an AI visibility score of 38 out of 100, based on 60 total AI mentions across platforms like Google AI Overview and ChatGPT. The brand generates 6.9K AI search volume. Compared to peers in the life sciences sector, Nihon Kohden ranks #6 of 6 in AI mention share of voice.
Nihon Kohden is a Japan-based medical device company in the Patient Monitoring segment, registered with the U.S. FDA. This report tracks how Nihon Kohden appears in AI search — ChatGPT, Google AI Overview and other answer engines.
Nihon Kohden has 60 total AI mentions across 2 tracked platforms, generating 6.9K in AI search volume. Google AI Overview accounts for the largest share at 90% of mentions.
No brand entity data available.
When AI assistants answer questions involving Nihon Kohden, these are the domains they most often cite. Winning AI visibility means being present and referenced on the sources the model actually reads — which is rarely a company's own website.
Nihon Kohden ranks #6 out of 6 competitors in AI mention share of voice, capturing 1% of total mentions. Dexcom leads with 7.8K AI mentions. Competitors tracked include Dexcom, Mindray, Masimo, Embecta.
| Company | Mentions | AI Vol |
|---|---|---|
| dexcom.com (Dexcom) | 7.8K | 14.7M |
| mindray.com (Mindray) | 985 | 505.0K |
| masimo.com (Masimo) | 430 | 94.2K |
| embecta.com (Embecta) | 127 | 25.6K |
| tandemdiabetes.com (Tandem Diabetes Care) | 85 | 1.5K |
| nihonkohden.com (You) | 60 | 6.9K |
This is a static snapshot. VayoMed helps life sciences brands monitor AI mentions, track competitors, and build the content and citation signals that make AI platforms more likely to recommend them.